Terms: = Uterine cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
5 results:
1. Medroxyprogesterone as the Initial Systemic treatment of Recurrent Endometrial cancer: A Single Institutional Study.
Korosue M; Nakagawa K; Yoshiyasu K; Narita S; Isono-Taniguchi R; Takimoto Y; Ueda T; Omote M; Wakimoto YU; Tsubamoto H; Hirota S; Shibahara H
Anticancer Res; 2023 Aug; 43(8):3693-3699. PubMed ID: 37500122
[TBL] [Abstract] [Full Text] [Related]
2. An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the treatment of Advanced and Recurrent Endometrial cancer.
Mathews C; Lorusso D; Coleman RL; Boklage S; Garside J
Oncologist; 2022 Dec; 27(12):1058-1066. PubMed ID: 36124638
[TBL] [Abstract] [Full Text] [Related]
3. Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
Alholm Z; Monk BJ; Ting J; Pulgar S; Boyd M; Sudharshan L; Bains S; Nicacio L; Coleman RL
Gynecol Oncol; 2021 May; 161(2):422-428. PubMed ID: 33741208
[TBL] [Abstract] [Full Text] [Related]
4. Influence of Morinda citrifolia (Noni) on Expression of DNA Repair Genes in Cervical cancer Cells.
Gupta RK; Bajpai D; Singh N
Asian Pac J Cancer Prev; 2015; 16(8):3457-61. PubMed ID: 25921162
[TBL] [Abstract] [Full Text] [Related]
5. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.
Chung HH; Kim MK; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2006 Dec; 103(3):1031-7. PubMed ID: 16875718
[TBL] [Abstract] [Full Text] [Related]